Gary W. Ashley

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.

Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY.

Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN.

Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.

Bluejay Therapeutics, Inc. is a clinical stage private biopharmaceutical company that is committed to developing effective treatments and cures for viral and liver diseases. The company is based in San Mateo, CA, and was founded by Keting Chu, who has been the CEO since incorporation. The company's first target indication is chronic hepatitis b, which is a worldwide prevalent disease with an urgent unmet medical need. Bluejay is advancing two innovative approaches with the potential for a high rate of functional cure: fully human igg1 anti-hbs monoclonal antibodies and first-in-class hbsag oral small molecule inhibitors. The company believes that by reducing hepatitis b surface antigen and restoring adaptive immunity, a functional cure could be achieved for patients.

Newyu, Inc. provides web-based health information services. It offers implementation, ongoing account management and customer support services. The company serves those monitoring asthma, diabetes, pulmonary disease, hypertension, cardiovascular disease and congestive heart failure. iMetrikus was founded by William J. Rutter in 1998 and is headquartered in Carlsbad, CA.

SynCo Bio Partners BV operates as a biopharmaceutical contract manufacturing company. It offers proteins, vaccines, and live microbial products. The firm offers a range of biopharmaceutical development and contract manufacturing services that support small biotechnology to large pharmaceutical organizations from the early stages in process development to preclinical and clinical trials, approval, and market supply worldwide. The company was founded by William J. Rutter in 2000 and is headquartered in Amsterdam, the Netherlands.

Cell Works Group, Inc. engages in designing therapeutics with engineering precision. It also offers drug development and recycling and repurposing services. The company was founded by Shireen Vali, Pradeep Fernandes and Taher Abbasi in June 2005 and is headquartered in San Jose, CA.

Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.

The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA.

Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China.

Blackfynn, Inc. provides treatments for neurological disease. Its new tools and technologies are generating. The company was founded by Amanda Christini and Joost Wagenaar and is headquartered in Philadelphia, PA.

Kemwell Pvt. Ltd. is a pharmaceutical manufacturing company founded in 1972. The private company is based in Bengaluru, India and has subsidiaries in Sweden. Ltd. specializes in the production of pharmaceuticals.

Part of Kemwell Biopharma Pvt Ltd., Cirrus Pharmaceuticals, Inc. provides formulations contract manufacturing and development services. The company is based in Durham, NC. The company was founded by Anthony J. Hickey. Ninad Deshpanday has been the CEO of the company since 2013. Cirrus Pharmaceuticals was acquired by Kemwell Biopharma Pvt Ltd. on July 26, 2013.

ReaMetrix India Pvt Ltd. provides biotechnology research services. The company was founded on January 17, 2002 and is headquartered in Bangalore, India.

Max Medisupport Pvt Ltd. provides healthcare ecosystem management solutions. The firm provides hospital planning, design and architecture, accreditation, information systems, hospital management, branding, marketing and international patient support systems. The company is headquartered in Bangalore, KA.

BioScience Advisors, Inc. engages in consulting and database firm focused on biopharma alliances. It specializes in biotechnology alliances, ip valuation, expert witness, pharmaceutical licenses, market trends, financial terms and contract provisions. The company was founded by Mark G. Edwardsin January 2011 and is headquartered in Walnut Creek, CA.

Recipharm (Americas), Inc. manufactures pharmaceutical products. The firm specializes in contract dosage form development, pharmaceutical manufacturing, analytical services, biopharmaceutical development and manufacturing services. The company is headquartered in Morrisville, NC.

Kemwell Biopharma Pvt Ltd. provides bio/pharmaceutical contract pharmaceutical development and manufacturing services. It delivers a portfolio of services for sterile and non-sterile products from preformulation to commercial supply. The firm offers formulation development, analytical support, clinical batch production, commercial-scale manufacturing, packing or global supply chain services. The company was founded in 1980 and is headquartered in Bangalore, India.

Part of Kemwell Biopharma Pvt Ltd., Kemwell AB is a Swedish company that offers pharmaceutical development and manufacturing services.

Part of Deloitte LLP (New York), Recombinant Capital, Inc. is a company that provides life sciences subscription database and advisory services. The company is based in Walnut Creek, CA. The company was founded by Mark G. Edwards. Recombinant Capital was acquired by Deloitte Touche Tohmatsu Services LLC on June 16, 2008.